Krilogy Financial’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Krilogy Financial’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-500	Closed	-$7K	–	854
2017 Q3	$7K	Hold	500	–	–	﹤0.01%	623
2017 Q2	$4K	Hold	500	–	–	﹤0.01%	624
2017 Q1	$2K	Hold	500	–	–	﹤0.01%	662
2016 Q4	$2K	Hold	500	–	–	﹤0.01%	662
2016 Q3	$2K	Hold	500	–	–	﹤0.01%	678
2016 Q2	$3K	Hold	500	–	–	﹤0.01%	666
2016 Q1	$3K	Hold	500	–	–	﹤0.01%	590
2015 Q4	$3K	Buy	+500	New	+$2.86K	﹤0.01%	362

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Krilogy Financial's SPPI Position: Q4 2017 in Review

Krilogy Financial sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2017, closing a stake of 500 shares — an estimated $7K sold.

Krilogy Financial first reported a position in SPPI in Q4 2015 and held it in 8 quarters. The position peaked at $7K in Q3 2017. 157 funds tracked by Wall St. Rank hold SPPI as of Q4 2017.

Krilogy Financial reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Krilogy Financial sold 500 Spectrum Pharmaceuticals Inc shares in Q4 2017, an estimated $7K.
Krilogy Financial first reported a position in Spectrum Pharmaceuticals Inc in Q4 2015 and held it in 8 quarters.
Krilogy Financial's Spectrum Pharmaceuticals Inc position peaked at $7K in Q3 2017.
157 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2017.

Based on Krilogy Financial's 13F filing for Q4 2017, filed 14 Feb 2018.